In vivo estimation of gluconeogenesis
PhD ceremony: Mr. S.K. Chacko, 11.00 uur, Academiegebouw, Broerstraat 5, Groningen
Title: In vivo estimation of gluconeogenesis
Promotor(s): prof. P.J.J. Sauer, prof. A.L. Sunehag
Faculty: Medical Sciences
Detailed knowledge about glucose kinetics is crucial to understand metabolic diseases and to optimize nutritional strategies. As a part of this thesis, we developed a simple, accurate and reproducible method based on mass spectroscopy to estimate in vivo rates of gluconeogenesis in different populations under various conditions to address a variety of metabolic issues.
The estimation of gluconeogenesis using the newly developed method enabled us to determine that gluconeogenesis accounts for the major part of glucose production and is an ongoing process in preterm infants even when glucose is supplied at rates exceeding their normal glucose turnover rate. We also reported that the incomplete suppression of glucose production observed in preterm infants is primarily due to the contribution from gluconeogenesis. Further, our investigations determined that gluconeogenesis is not acutely regulated by either insulin or glucose concentrations in very preterm infants receiving total parenteral nutrition.
These findings are crucial to optimize nutritional strategies in premature infants. The results suggest that supplying glucose at rates corresponding to normal infant glucose turnover rate (in addition to glucose produced via gluconeogenesis utilizing the supplied gluconegenic substrates via TPN) is a potential strategy to prevent hypo/hyperglycemia in infants during their early days of life.
In this thesis we also reported that the extra glucose demands of lactation during the extended periods of fasting in lactating women are met by increasing gluconeogenesis. Further investigations of this thesis using a mice model determined that ghrelin plays a role in the regulation of gluconeogenesis/glycogenolysis and that the absence of ghrelin action has a beneficial outcome on glucose metabolism.
Last modified: | 13 March 2020 01.10 a.m. |
More news
-
27 August 2024
UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling
Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...
-
17 July 2024
Veni-grants for ten researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.
-
16 July 2024
Medicine still subjects to male bias
Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.